title: Defining arrhythmic risk and defibrillator therapy in ARVC: shocking rhythm?
authors.affiliation: University of California Medical Center, San Diego, California.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: McGarry
authors.affiliation: University of California Medical Center, San Diego, California. Electronic address: snarayan@ucsd.edu.
authors.forename: Sanjiv M
authors.initials: SM
authors.lastname: Narayan
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000150:complications*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology*; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D008297:Male; D012042:Registries; D017180:Tachycardia, Ventricular / Q000453:epidemiology*
chemical_list: D000889:Anti-Arrhythmia Agents
keywords: ICD therapy; anti-tachycardia pacing; arrhythmogenic right ventricular cardiomyopathy (ARVC); risk stratification